JPWO2020064549A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020064549A5 JPWO2020064549A5 JP2021514976A JP2021514976A JPWO2020064549A5 JP WO2020064549 A5 JPWO2020064549 A5 JP WO2020064549A5 JP 2021514976 A JP2021514976 A JP 2021514976A JP 2021514976 A JP2021514976 A JP 2021514976A JP WO2020064549 A5 JPWO2020064549 A5 JP WO2020064549A5
- Authority
- JP
- Japan
- Prior art keywords
- wax
- composition
- composition according
- perfluorobutyl
- solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 20
- 239000001993 wax Substances 0.000 claims 7
- 239000002562 thickening agent Substances 0.000 claims 6
- 150000001335 aliphatic alkanes Chemical class 0.000 claims 5
- 239000007787 solid Substances 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 3
- 239000004166 Lanolin Substances 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 2
- 230000004888 barrier function Effects 0.000 claims 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 claims 2
- 235000019388 lanolin Nutrition 0.000 claims 2
- 150000002632 lipids Chemical class 0.000 claims 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 claims 2
- WCOXQTXVACYMLM-UHFFFAOYSA-N 2,3-bis(12-hydroxyoctadecanoyloxy)propyl 12-hydroxyoctadecanoate Chemical compound CCCCCCC(O)CCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC(O)CCCCCC)COC(=O)CCCCCCCCCCC(O)CCCCCC WCOXQTXVACYMLM-UHFFFAOYSA-N 0.000 claims 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 claims 1
- 208000002874 Acne Vulgaris Diseases 0.000 claims 1
- 244000146553 Ceiba pentandra Species 0.000 claims 1
- 235000003301 Ceiba pentandra Nutrition 0.000 claims 1
- 241000283153 Cetacea Species 0.000 claims 1
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 206010012442 Dermatitis contact Diseases 0.000 claims 1
- 206010013786 Dry skin Diseases 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 240000000111 Saccharum officinarum Species 0.000 claims 1
- 235000007201 Saccharum officinarum Nutrition 0.000 claims 1
- 229930003316 Vitamin D Natural products 0.000 claims 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims 1
- 206010000496 acne Diseases 0.000 claims 1
- 230000032683 aging Effects 0.000 claims 1
- 208000002029 allergic contact dermatitis Diseases 0.000 claims 1
- 239000012164 animal wax Substances 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 235000013871 bee wax Nutrition 0.000 claims 1
- 239000012166 beeswax Substances 0.000 claims 1
- 235000021028 berry Nutrition 0.000 claims 1
- 229940046731 calcineurin inhibitors Drugs 0.000 claims 1
- 239000004204 candelilla wax Substances 0.000 claims 1
- 235000013868 candelilla wax Nutrition 0.000 claims 1
- 229940073532 candelilla wax Drugs 0.000 claims 1
- 239000004203 carnauba wax Substances 0.000 claims 1
- 235000013869 carnauba wax Nutrition 0.000 claims 1
- 239000012185 ceresin wax Substances 0.000 claims 1
- 229960000541 cetyl alcohol Drugs 0.000 claims 1
- 229940074979 cetyl palmitate Drugs 0.000 claims 1
- 239000003246 corticosteroid Substances 0.000 claims 1
- 229960001334 corticosteroids Drugs 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000037336 dry skin Effects 0.000 claims 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 claims 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 claims 1
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Substances CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims 1
- 208000001875 irritant dermatitis Diseases 0.000 claims 1
- 230000007803 itching Effects 0.000 claims 1
- 229940119170 jojoba wax Drugs 0.000 claims 1
- 229940039717 lanolin Drugs 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000000155 melt Substances 0.000 claims 1
- 239000012170 montan wax Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000012188 paraffin wax Substances 0.000 claims 1
- 239000012169 petroleum derived wax Substances 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 239000004170 rice bran wax Substances 0.000 claims 1
- 235000019384 rice bran wax Nutrition 0.000 claims 1
- 239000012176 shellac wax Substances 0.000 claims 1
- 239000008247 solid mixture Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 150000003626 triacylglycerols Chemical class 0.000 claims 1
- 239000012178 vegetable wax Substances 0.000 claims 1
- 235000019166 vitamin D Nutrition 0.000 claims 1
- 239000011710 vitamin D Substances 0.000 claims 1
- 150000003710 vitamin D derivatives Chemical class 0.000 claims 1
- 229940046008 vitamin d Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18197200 | 2018-09-27 | ||
| EP18197200.1 | 2018-09-27 | ||
| PCT/EP2019/075345 WO2020064549A1 (en) | 2018-09-27 | 2019-09-20 | Lipid barrier repair |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022501345A JP2022501345A (ja) | 2022-01-06 |
| JP2022501345A5 JP2022501345A5 (https=) | 2022-09-28 |
| JPWO2020064549A5 true JPWO2020064549A5 (https=) | 2022-09-28 |
| JP7360452B2 JP7360452B2 (ja) | 2023-10-12 |
Family
ID=63685885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514976A Active JP7360452B2 (ja) | 2018-09-27 | 2019-09-20 | 脂質バリアの修復 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US12029757B2 (https=) |
| EP (1) | EP3856124A1 (https=) |
| JP (1) | JP7360452B2 (https=) |
| KR (1) | KR102808092B1 (https=) |
| CN (1) | CN112839620A (https=) |
| CA (1) | CA3112504A1 (https=) |
| WO (1) | WO2020064549A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107397718A (zh) | 2011-05-25 | 2017-11-28 | 诺瓦利克有限责任公司 | 基于半氟化烷烃类的外用药物组合物 |
| PT3399962T (pt) | 2016-12-23 | 2020-09-03 | Novaliq Gmbh | Composição oftálmica para o tratamento da doença do olho seco |
| CA3058097C (en) | 2017-04-21 | 2024-01-02 | Novaliq Gmbh | Iodine compositions |
| CN111182893A (zh) | 2017-10-04 | 2020-05-19 | 诺瓦利克有限责任公司 | 包含f6h8的眼用组合物 |
| WO2020064556A1 (en) | 2018-09-27 | 2020-04-02 | Novaliq Gmbh | Topical sunscreen formulation |
| CN113710228A (zh) | 2019-02-13 | 2021-11-26 | 诺瓦利克有限责任公司 | 用于治疗眼部新生血管形成的组合物和方法 |
| US12419933B2 (en) | 2019-09-06 | 2025-09-23 | Novaliq Gmbh | Ophthalmic composition for the treatment of uveitis |
| EP3861857A1 (en) * | 2020-02-07 | 2021-08-11 | Novaliq GmbH | Antiparasitic compositions |
| WO2026037894A1 (en) * | 2024-08-15 | 2026-02-19 | Dermaliq Therapeutics, Inc. | Semifluorinated alkane compositions for cleaning the skin |
Family Cites Families (80)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2616927A (en) | 1950-05-12 | 1952-11-04 | Minnesota Mining & Mfg | Fluorocarbon tertiary amines |
| JPS5721312A (en) * | 1980-07-12 | 1982-02-04 | Green Cross Corp:The | Breathable ointment |
| US5077036A (en) | 1986-01-14 | 1991-12-31 | Alliance Pharmaceutical Corp. | Biocompatible stable fluorocarbon emulsions for contrast enhancement and oxygen transport comprising 40-125% wt./volume fluorocarbon combined with a phospholipid |
| JPH0764702B2 (ja) | 1986-04-23 | 1995-07-12 | 鐘紡株式会社 | 多相乳化型化粧料 |
| JPH03279323A (ja) | 1989-12-15 | 1991-12-10 | Johnson & Johnson Consumer Prod Inc | 日焼け止め組成物 |
| JP3046346B2 (ja) | 1990-03-12 | 2000-05-29 | 昭和電工株式会社 | 外用剤基剤又は補助剤とそれを含有する人又は動物の外用剤 |
| US5518731A (en) | 1990-09-27 | 1996-05-21 | Allergan, Inc. | Nonaqueous fluorinated drug delivery vehicle suspensions |
| US5152997A (en) | 1990-12-11 | 1992-10-06 | Theratech, Inc. | Method and device for transdermally administering testosterone across nonscrotal skin at therapeutically effective levels |
| US5326566A (en) | 1991-05-17 | 1994-07-05 | Bristol-Myers Squibb Company | Use of dibutyl adipate and isopropyl myristate in topical and transdermal products |
| FR2679150A1 (fr) | 1991-07-17 | 1993-01-22 | Atta | Preparations comprenant un fluorocarbure ou compose hautement fluore et un compose organique lipophile-fluorophile, et leurs utilisations. |
| DE4405627A1 (de) * | 1994-02-22 | 1995-08-24 | Hoechst Ag | Fluorkohlenwasserstoffe enthaltende Ölemulsionen |
| FR2720943B1 (fr) | 1994-06-09 | 1996-08-23 | Applic Transferts Technolo | Emulsions inverses stables à forte concentration en composé(s) fluoré(s) et leur utilisation pour l'administration pulmonaire de médicaments et pour la fabrication d'émulsions multiples. |
| US5696164A (en) | 1994-12-22 | 1997-12-09 | Johnson & Johnson Consumer Products, Inc. | Antifungal treatment of nails |
| US5667809A (en) | 1995-06-07 | 1997-09-16 | Alliance Pharmaceutical Corp. | Continuous fluorochemical microdispersions for the delivery of lipophilic pharmaceutical agents |
| US5874481A (en) | 1995-06-07 | 1999-02-23 | Alliance Pharmaceutical Corp. | Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents |
| DE19536504C2 (de) * | 1995-09-29 | 1999-09-23 | H Meinert | Verwendung fluorierter Alkane |
| US5874469A (en) | 1996-01-05 | 1999-02-23 | Alcon Laboratories, Inc. | Fluoroalkyl hydrocarbons for administering water insoluble or unstable drugs |
| RU2111738C1 (ru) | 1996-06-24 | 1998-05-27 | Акционерное общество "НИЗАР" | Средство для усиления солнцезащитной активности фотозащитных агентов |
| FR2752161B1 (fr) | 1996-08-07 | 1998-09-25 | Atta | Emulsions multiples de type hydrocarbure-dans-eau-dans- fluorocarbone pour le transport de substances medicamenteuses hydrophiles et/ou lipophiles |
| US5863560A (en) | 1996-09-11 | 1999-01-26 | Virotex Corporation | Compositions and methods for topical application of therapeutic agents |
| US5980936A (en) | 1997-08-07 | 1999-11-09 | Alliance Pharmaceutical Corp. | Multiple emulsions comprising a hydrophobic continuous phase |
| DK0983037T3 (da) | 1998-02-09 | 2003-09-01 | Macrochem Corp | Fungicid neglelak |
| US6159977A (en) | 1998-11-16 | 2000-12-12 | Astan, Inc. | Therapeutic anti-fungal nail preparation |
| EP1152749B1 (en) | 1999-02-08 | 2006-04-12 | ALZA Corporation | Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles |
| US6528086B2 (en) | 1999-09-28 | 2003-03-04 | Zars, Inc. | Methods and apparatus for drug delivery involving phase changing formulations |
| US20060204458A1 (en) | 2000-10-26 | 2006-09-14 | Holloway William D Jr | Anti-aging methods and composition |
| DE10024413A1 (de) | 2000-05-19 | 2001-12-06 | Mika Pharma Gmbh | Pharmazeutische und/oder kosmetische Zubereitung |
| DE10042412B4 (de) | 2000-08-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung |
| WO2002089849A1 (en) | 2001-05-07 | 2002-11-14 | Corium International | Compositions and delivery systems for administration of a local anesthetic agent |
| DE60223694T2 (de) | 2001-09-04 | 2008-10-30 | Trommsdorff Gmbh & Co. Kg Arzneimittel | Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums |
| US20050084553A1 (en) | 2002-01-26 | 2005-04-21 | Woong-Sig Moon | Composition containing moutan root bark extract as active ingredient |
| EP1663148A2 (en) | 2003-08-25 | 2006-06-07 | Foamix Ltd. | Penetrating pharmaceutical foam |
| US20050079210A1 (en) | 2003-10-09 | 2005-04-14 | Gupta Shyam K. | Liposomal delivery system for topical pharmaceutical, cosmeceutical, and cosmetic ingredients |
| DK1670433T3 (da) | 2003-10-10 | 2012-03-12 | Ferring Bv | Transdermal farmaceutisk formulering til mindskelse af hudrester |
| JP2007511616A (ja) | 2003-11-19 | 2007-05-10 | バーンズ−ジューイッシュ ホスピタル | 増強された薬物送達 |
| GB0408164D0 (en) | 2004-04-13 | 2004-05-19 | Immune Targeting Systems Ltd | Antigen delivery vectors and constructs |
| WO2005099718A1 (en) | 2004-04-19 | 2005-10-27 | Centre National De La Recherche Scientifique (C.N.R.S.) | Lung surfactant supplements |
| JP2008501806A (ja) | 2004-06-08 | 2008-01-24 | オキュラリス ファーマ， インコーポレイテッド | 疎水性眼用組成物および使用方法 |
| US7740875B2 (en) | 2004-10-08 | 2010-06-22 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
| US20060078580A1 (en) | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
| EP1688161A1 (en) | 2004-11-02 | 2006-08-09 | Switch Biotech Aktiengesellschaft | Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis |
| GB0511499D0 (en) | 2005-06-06 | 2005-07-13 | Medpharm Ltd | Topical ungual formulations |
| FR2892023B1 (fr) | 2005-10-14 | 2009-09-25 | Galderma Sa | Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale |
| DE102005050431A1 (de) | 2005-10-21 | 2007-04-26 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe |
| DE102005055811A1 (de) | 2005-11-23 | 2007-05-31 | Novaliq Gmbh | Verwendung einer Zusammensetzung zur Konservierung von Organen und Gliedmaßen |
| TWI376239B (en) | 2006-02-01 | 2012-11-11 | Andrew Xian Chen | Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| AU2008300013A1 (en) | 2007-09-07 | 2009-03-19 | Qlt Inc. | Drug cores for sustained release of therapeutic agents |
| EP2110126B9 (de) | 2008-04-18 | 2012-09-19 | Novaliq GmbH | Inhalative und instillative Verwendung von semifluorierten Alkanen als Wirkstoffträger im intrapulmonalen Bereich |
| SI2387391T1 (sl) | 2009-07-24 | 2017-04-26 | Mika Pharma Gesellschaft Fuer Die Entwicklung Und Vermarktung Pharmazeutischer Produkte Mbh | Postopek za pripravo tekočega sestavka, ki se nanaša na kožo v obliki pene, in sestavka, ki se lahko nanaša topično |
| EP2332525A1 (en) | 2009-11-23 | 2011-06-15 | Novaliq GmbH | Pharmaceutical composition comprising propofol |
| EP2335735A1 (en) | 2009-12-14 | 2011-06-22 | Novaliq GmbH | Pharmaceutical composition for treatment of dry eye syndrome |
| WO2011113855A2 (en) | 2010-03-17 | 2011-09-22 | Novaliq Gmbh | Pharmaceutical composition for treatment of increased intraocular pressure |
| DE102010022567A1 (de) | 2010-06-02 | 2011-12-08 | Fluoron Gmbh | Zubereitung |
| HUP1000362A2 (en) | 2010-07-12 | 2012-11-28 | Egis Gyogyszergyar Nyrt | Antiseptic and disinfecting compositions having reduced iodine content |
| EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
| US20120100183A1 (en) | 2010-10-23 | 2012-04-26 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
| EP2462921A1 (en) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
| DK2661280T3 (en) | 2011-01-04 | 2019-03-04 | Novaliq Gmbh | O / V EMULSIONS INCLUDING SEMIFLUORINATED ALKANES |
| US20120219640A1 (en) | 2011-02-25 | 2012-08-30 | Wright Kenneth W | Anti-infective solution for athlete's foot |
| CN107397718A (zh) * | 2011-05-25 | 2017-11-28 | 诺瓦利克有限责任公司 | 基于半氟化烷烃类的外用药物组合物 |
| KR101773648B1 (ko) | 2011-05-25 | 2017-08-31 | 노바리크 게엠베하 | 조갑에 투여를 위한 제약학적 조성물 |
| US8758826B2 (en) | 2011-07-05 | 2014-06-24 | Wet Inc. | Cannabinoid receptor binding agents, compositions, and methods |
| KR101989648B1 (ko) | 2012-01-23 | 2019-06-14 | 노바리크 게엠베하 | 부분불소화 알칸에 기초한 안정화된 단백질 조성물 |
| EP2863888A1 (en) * | 2012-06-25 | 2015-04-29 | Bayer HealthCare LLC | Topical ophthalmological pharmaceutical composition containing axitinib |
| DK3181119T3 (da) | 2012-09-12 | 2019-09-16 | Novaliq Gmbh | Semifluorerede alkansammensætninger til anvendelse ved behandling af keratoconjunctivitis sicca |
| CN113679697A (zh) | 2012-09-12 | 2021-11-23 | 诺瓦利克有限责任公司 | 包含半氟化烷烃的混合物的组合物 |
| EP2783703A1 (en) | 2013-03-25 | 2014-10-01 | B. Braun Melsungen AG | Semifluorocarbon compound containing contrast agent |
| BR112016001522B1 (pt) | 2013-07-23 | 2019-10-01 | Novaliq Gmbh | Composições de anticorpo estabilizado |
| EP2944324A1 (de) * | 2014-05-13 | 2015-11-18 | LTS LOHMANN Therapie-Systeme AG | Verwendung von semifluorierten Alkanen in transdermalen therapeutischen Systemen |
| US9186305B1 (en) | 2014-05-19 | 2015-11-17 | Shiseido Company, Ltd. | Sunscreen products in which excessive whiteness due to titanium dioxide and zinc oxide is visually masked upon skin application |
| MX2018003781A (es) | 2015-09-30 | 2018-09-12 | Novaliq Gmbh | Compuestos semifluorados para administracion oftalmica. |
| CN108348777B (zh) | 2015-09-30 | 2020-04-28 | 诺瓦利克有限责任公司 | 半氟化化合物和其组合物 |
| CA2983765C (en) | 2016-06-08 | 2018-02-27 | Majda Ficko | Sun block formulation |
| USRE50060E1 (en) | 2016-06-23 | 2024-07-30 | Novaliq Gmbh | Topical administration method |
| CN106176937A (zh) * | 2016-08-24 | 2016-12-07 | 刘艺鹏 | 湿疹、痤疮软膏 |
| CA3058097C (en) * | 2017-04-21 | 2024-01-02 | Novaliq Gmbh | Iodine compositions |
| US20210069014A1 (en) | 2017-05-06 | 2021-03-11 | Novaliq Gmbh | Drop dispenser |
| WO2020064556A1 (en) | 2018-09-27 | 2020-04-02 | Novaliq Gmbh | Topical sunscreen formulation |
| IL283357B2 (en) | 2018-11-27 | 2025-05-01 | Novaliq Gmbh | Semifluorinated alkane preparations containing omega-3 fatty acid ethyl esters |
| EP3861857A1 (en) | 2020-02-07 | 2021-08-11 | Novaliq GmbH | Antiparasitic compositions |
-
2019
- 2019-09-20 WO PCT/EP2019/075345 patent/WO2020064549A1/en not_active Ceased
- 2019-09-20 US US17/279,067 patent/US12029757B2/en active Active
- 2019-09-20 EP EP19769528.1A patent/EP3856124A1/en active Pending
- 2019-09-20 KR KR1020217009953A patent/KR102808092B1/ko active Active
- 2019-09-20 CN CN201980062527.8A patent/CN112839620A/zh active Pending
- 2019-09-20 JP JP2021514976A patent/JP7360452B2/ja active Active
- 2019-09-20 CA CA3112504A patent/CA3112504A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022501345A5 (https=) | ||
| JPWO2020064549A5 (https=) | ||
| EP0335115B1 (fr) | Compositions pharmaceutiques et cosmétiques à base de peroxyde de benzoyle et de sels d'ammonium quaternaires | |
| JP7360452B2 (ja) | 脂質バリアの修復 | |
| PL188708B1 (pl) | Zastosowanie, w kompozycji, wyciągu z przynajmniej jednej rośliny z rodziny Labiatae (wargowych) z rodzaju Rosmarinus uprawianej in vitro i kompozycja zawierająca ten wyciąg | |
| CN1103584C (zh) | 凡士林膏 | |
| JP2023154020A5 (https=) | ||
| EP2125117A2 (fr) | Emulsion comprenant au moins un retinoide et du péroxyde de benzoyle | |
| KR20090091308A (ko) | 하나 이상의 레티노이드 및 벤조일 퍼옥시드를 포함하는 크림 젤 | |
| CN105997613A (zh) | 一种敏感修复型卸妆油及其制备方法 | |
| AU758594B2 (en) | Method and composition for treating acne | |
| HU227318B1 (en) | Cosmetical and dematological composition for treating, grooming of psoric skin and scalp | |
| JPS6330884B2 (https=) | ||
| JP2022501343A5 (https=) | ||
| JP5079689B2 (ja) | 油性軟膏と可溶化された形態のビタミンｄまたはその誘導体とを含む薬剤組成物 | |
| EP1603517B1 (en) | Skin care product containing tall oil fatty acids and vegetable oils for dry and scaling skin and treatment of psoriasis, dermatitis, and eczemas | |
| CN104602697A (zh) | 用于治疗银屑病的组合物 | |
| WO2009092954A1 (fr) | Composition comprenant un retinoide et du peroxyde de benzoyle disperse | |
| US20050281848A1 (en) | Oleaginous ointments comprising two solubilized bioactive agents for the treatment of psoriasis | |
| JPH0729928B2 (ja) | ハイドロコ−チゾンジエステル含有クリ−ム | |
| CN101355926B (zh) | 植物果肉的不皂化提取物在治疗皮肤老化中的用途 | |
| EP3151816B1 (fr) | Composition dermatologique à base de niacinamide | |
| JPH06511494A (ja) | 皮膚再生化粧用製剤 | |
| EP0223671A1 (fr) | Médicament à action synergétique anti-inflammatoire à base d'un corticostéroide et d'un beta-agoniste | |
| CA2672377A1 (fr) | Utilisation du nepafenac ou ses derives pour le traitement de desordres dermatologiques liees a un desordre de la keratinisation pouvant avoir une composante immuno-allergique inflammatoire |